KENYA – The Kenyatta University Teaching Research and Referral Hospital (KUTRRH), Kenya’s leading national referral hospital, has purchased a cutting-edge CyberKnife System for the applied use of treating tumors throughout the entire body.
The world’s only robotic radiosurgery system known as CyberKnife Stereotactic Radiosurgery System will be used by medical experts to offer personalized treatments of various types of cancers including brain tumors, head and neck cancer, lung, breast, spinal, liver, pancreas and prostate cancers.
According to KUTRRH, the new Cyberknife device is a key cancer treatment machine that offers a painless and non-invasive treatment for cancerous & non-cancerous tumors while limiting exposure to surrounding healthy tissues and critical structures.
“Upon installation, the CyberKnife’s stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system will enable clinicians at KUTRRH to confidently deliver precise, highly effective hypo fractionated radiation treatments,” the hospital said on its official website.
The CyberKnife System is the only robotic radiosurgery system that offers highly precise, non-surgical treatment for tumors and lesions anywhere in the body—including the brain, breast, kidney, liver, lung, pancreas, prostate and spine.
The Kenyatta University Teaching, Referral and Research Hospital announced that the KUTRRH Cyberknife is set to revolutionize cancer treatment not only in Kenya but also in the region as it is the second of its kind in Africa after Egypt.
The CyberKnife machine is designed to use robotics in conjunction with image guidance technology to precisely deliver pulses of high-dose radiation that target certain tumors and other abnormal tissues anywhere in the body.
Furthermore, the introduction of the CyberKnife treatment in Kenya is in line with Kenyatta University Hospital’s commitment to bring the latest innovations to its patients’ care including cancer treatments particularly surgery, radiation and chemotherapy.
KUTRRH highlighted that the CyberKnife technology will be able to reach areas of the body previously thought untreatable thus the device can treat a variety of tumors and cancers, noting that the device offers patients a non-invasive alternative to surgery.
The Kenyan national referral hospital pointed out that CyberKnife-based stereotactic radiosurgery is painless and has a shorter treatment with almost immediate recovery while precision treatment limits damage to healthy tissue hence very few side effects.
“Movement of the tumor during treatment caused by coughing, breathing or swallowing does not alter precision since the CyberKnife machine automatically adjusts the radiation beams accordingly,” explained KUTRRH.
Furthermore, CyberKnife is radiation therapy, not surgery, hence the treatment is ideal for patients unable to undergo surgery or who
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
